3.990USD-0.25%Mkt Cap: 1.77B USDP/E: —Last update: 2026-06-01
Iovance Biotherapeutics, Inc., a commercial-stage biopharmaceutical company, develops and commercializes cell therapies using autologous tumor infiltrating lymphocyte for the treatment of metastatic melanoma and other so…
Industry Peers
Biotechnology111.39BUSDP/E 26.0
100.62BDKKP/E 19.4
62.97BUSDP/E 14.7
48.39BEURP/E 31.7
44.65BEURP/E 37.2
40.10BUSDP/E 75.3
35.22BUSD—
32.91BSEKP/E 48.6
Indicators:|
Key Statistics
Company
Market Cap1.77B USD
Enterprise Value1.56B USD
Revenue (TTM)285.61M USD
Gross Profit90.32M USD
Net Income (TTM)-390.98M USD
Revenue/Share0.7490 USD
Last Price3.990 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees975
CountryUS
SectorHealthcare
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)-12.85
PEG—
EV/EBITDA-4.87
EV/Revenue5.48
P/S6.41
P/B2.49
EPS (TTM)-0.92
EPS (Forward)-0.32
52W Range
1.66059% of range5.630
52W High5.630 USD
52W Low1.660 USD
Profitability
Gross Margin34.28%
Oper. Margin-113.46%
EBITDA Margin-112.61%
Profit Margin-148.38%
ROE-55.97%
ROA-42.82%
Growth
Revenue Growth44.80%
Earnings Growth—
Cash Flow & Leverage
Operating CF-302.41M USD
CapEx (TTM)33.84M USD
FCF Margin-52.19%
FCF Yield-8.40%
Net Debt-265.67M USD
Net Debt/EBITDA0.83
Balance Sheet
Debt/Equity0.07
Current Ratio3.60
Quick Ratio3.05
Book Value/Sh1.647 USD
Cash/Share0.7020 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Splits
Last Split1:100
Split DateSep 26, 2013
Analyst Consensus
Rating1.6 (Buy)
Target (Mean)8.800 USD
Target Range4.000 USD – 14.00 USD
# Analysts10
Ownership
Shares Out.446.50M
Float387.98M
Insiders0.33%
Institutions67.47%
Short Interest
Short Ratio7.0d
Short % Float25.56%
Short % Out.23.88%
Shares Short106.61M
Short (prev mo.)108.80M
Technical
SMA 503.648 (+9.4%)
SMA 2002.852 (+39.9%)
Beta0.69
S&P 52W Chg27.94%
Avg Vol (30d)14.21M
Avg Vol (10d)11.83M
Technical Indicators
RSI (14)55.7
MACD0.1300
MACD Signal0.0610
MACD Hist.+0.0689
BB Upper4.361 USD
BB Middle3.761 USD
BB Lower3.162 USD
BB Width31.89%
ATR (14)0.2965 USD
Vol Ratio (20d)0.83x